Nowalk MP, Smith KJ, Raviotta JM, Wateska A, et al. Cost-effectiveness of recombinant influenza vaccine compared with standard dose influenza vaccine in adults 18-64 years of age. Vaccine 2024 Jul 5:S0264-410X(24)00748-5. doi: 10.1016/j.vaccine.2024.
PMID: 38971665